E-DRUG: Launch of new WHO web site on substandard & falsified medicines
----------------------------------------------------------------------------------------
The existence of substandard, spurious, falsely labelled, falsified and counterfeit (SSFFC) medical products is an unacceptable risk to public health. They affect every region of the world, and medicines from all major therapeutic categories have been reported, including vaccines and diagnostics. They harm patients and undermine confidence in medical products, healthcare professionals and health systems.
WHO is working with stakeholders to minimize the risks from SSFFC medical products by collecting data and transferring knowledge and good practices to countries.
Have a look at this website:
http://www.who.int/medicines/regulation/ssffc/en/
Daniela Bagozzi
Information and communication
WHO/Essential Medicines and Health Products
E-mail: bagozzid@who.int